Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
94 |
issn |
1174-5886 1179-6901 |
issueIdentifier |
2 |
pageRange |
91-94 |
publicationName |
Drugs in R & D |
startingPage |
91 |
bibliographicCitation |
Beclometasone oral--DOR BioPharma. Drugs R D. 2007;8(2):91–4. doi: 10.2165/00126839-200708020-00003. PMID: 17324006. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09674209e11499b5f89e624a13e843a6 |
date |
200703 |
identifier |
https://doi.org/10.2165/00126839-200708020-00003 https://pubmed.ncbi.nlm.nih.gov/17324006 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21561 https://portal.issn.org/resource/ISSN/1179-6901 https://portal.issn.org/resource/ISSN/1174-5886 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Beclometasone Oral — DOR BioPharma |
discusses |
http://id.nlm.nih.gov/mesh/M0020994 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0002258 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7874 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10792 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20469 |